|
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an in vivo Model of Invasive Pulmonary Aspergillosis. |
05-Apr |
Article |
|
|
|
International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients. |
05-Apr |
Article |
|
|
|
Acute invasive fungal rhinosinusitis: our 2 year experience and outcome analysis. |
05-Apr |
Article |
|
|
|
Leukopenia induced by micafungin in a bottlenose dolphin (Tursiops truncatus): a case report. |
05-Apr |
Article |
|
|
|
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus. |
05-Apr |
Article |
|
|
|
Advances in antifungal drug measurement by liquid chromatography-mass spectrometry. |
05-Apr |
Article |
|
|
|
Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers. |
05-Apr |
Article |
|
|
|
Voriconazole: A Review of Population Pharmacokinetic Analyses. |
05-Apr |
Article |
|
|
|
A pharmacokinetic model for voriconazole in a highly diversified population of children and adolescents with cancer. |
05-Apr |
Article |
|
|
|
Itraconazole induces regression of infantile hemangioma via down-regulation of the PDGF-D/PI3K/Akt/mTOR pathway. |
05-Apr |
Article |
|
|
